Efficacy of Peginterferon Alfa-2b (SCH 054031) vs Glycyrrhizin in Interferon (IFN)-Treated Patients With Chronic Hepatitis C and F2/F3 Liver Fibrosis (P04773)
Clinical trial NCT00686881 · TERMINATED
Trial details
- NCT number
- NCT00686881
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2011-02-01
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.